These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14173)

  • 21. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():265-71. PubMed ID: 6938003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic calcium oxalate urolithiasis.
    Smith LH
    Endocrinol Metab Clin North Am; 1990 Dec; 19(4):937-47. PubMed ID: 2081520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of crystalluria in diabetic patients].
    Mbarki M; Jabrane J; Oussama A; Daudon M
    Prog Urol; 2005 Jun; 15(3):420-5; discussion 425-6. PubMed ID: 16097146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent uric acid stones.
    Kamel KS; Cheema-Dhadli S; Shafiee MA; Davids MR; Halperin ML
    QJM; 2005 Jan; 98(1):57-68. PubMed ID: 15625355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of urate on calcium oxalate crystallization in human urine: evidence for a promotory role of hyperuricosuria in urolithiasis.
    Grover PK; Ryall RL; Marshall VR
    Clin Sci (Lond); 1990 Jul; 79(1):9-15. PubMed ID: 2167797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of sodium-potassium citrate therapy on the circadian rhythm of urinary uric acid and urate saturation in normal individuals.
    Ogawa Y
    Hinyokika Kiyo; 1993 Oct; 39(10):883-90. PubMed ID: 8266850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Laboratory methods of predicting primary and recurrent nephrolithiasis].
    Alchinbaev MK; Malik AM; Merkusheva NV; Makhonina IA
    Urologiia; 2000; (5):9-10. PubMed ID: 11392229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The care of patients with urate calculi].
    Szendröi Z
    Z Urol Nephrol; 1979 May; 72(5):359-63. PubMed ID: 39392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fundamental bases of urinary oxalo-calcic lithogenesis].
    Robert M; Averous M
    J Urol (Paris); 1994; 100(1):40-2. PubMed ID: 8089531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic treatment of uric acid calculi.
    Preminger GM
    Urol Clin North Am; 1987 May; 14(2):335-8. PubMed ID: 3576854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of a vegetarian and different omnivorous diets on urinary risk factors for uric acid stone formation.
    Siener R; Hesse A
    Eur J Nutr; 2003 Dec; 42(6):332-7. PubMed ID: 14673606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M; Kawamura J; Ueda M; Okada Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary calculi associated with purine metabolism. Uric acid nephrolithiasis.
    Williams-Larson AW
    Endocrinol Metab Clin North Am; 1990 Dec; 19(4):821-38. PubMed ID: 2081513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The influence of uric acid on the calcium oxalate stone formation (author's transl)].
    Matouschek E; Huber R
    Urologe A; 1979 Jul; 18(4):211-4. PubMed ID: 38552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the diurnal variation of urinary pH and urinary calcium in urolithiasis: a study in outpatients.
    Murayama T; Sakai N; Yamada T; Takano T
    Int J Urol; 2001 Oct; 8(10):525-31; discussion 532. PubMed ID: 11737477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uricosuric therapy and urate solubility in blood and urine.
    Gröbner W; Zöllner N
    Postgrad Med J; 1979; 55 Suppl 3():26-31. PubMed ID: 504037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine is a saturated equilibrium and not a metastable supersaturated solution: evidence from crystalluria and the general composition of calcium salt and uric acid calculi.
    Ashby RA; Byrne JP; Györy AZ
    Urol Res; 1999 Oct; 27(5):297-305. PubMed ID: 10550515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of a high dietary intake of purine-rich animal protein on urinary urate excretion and supersaturation in renal stone disease.
    Fellström B; Danielson BG; Karlström B; Lithell H; Ljunghall S; Vessby B
    Clin Sci (Lond); 1983 Apr; 64(4):399-405. PubMed ID: 6825409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.